Raymond James Files 8-K with Financial Exhibits

TL;DR

RJF filed an 8-K, mostly financial exhibits. Nothing major to see here.

AI Summary

Raymond James Financial, Inc. filed an 8-K on December 4, 2025, reporting events as of December 3, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events or regulatory disclosures detailed in the provided text.

Why It Matters

This filing indicates Raymond James Financial is providing updated financial information or exhibits to the SEC, which is standard practice for public companies.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any significant new risks or material adverse events.

Key Players & Entities

• RAYMOND JAMES FINANCIAL, INC. (company) — Registrant
• 0000720005-25-000095 (filing_id) — Accession Number
• December 3, 2025 (date) — Date of earliest event reported
• December 4, 2025 (date) — Filing Date
• 880 Carillon Parkway St. Petersburg Florida 33716 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.54 — ecember 3, 2025 a quarterly dividend of $0.54 per share for each outstanding share of
• $0.3984375 — d declared a quarterly cash dividend of $0.3984375 per depositary share of 6.375% Fixed-to
• $2 billion — Stock") in an aggregate amount of up to $2 billion. The $2 billion authorization replaces
• $1.5 billion — he previous repurchase authorization of $1.5 billion announced on December 3, 2024, under wh
• $105 million — mber 3, 2024, under which approximately $105 million was remaining as of December 2, 2025. T

Filing Documents

• rjf-20251203.htm (8-K) — 30KB
• ex991_rjf20251203releasediv.htm (EX-99.1) — 9KB
• image_0a.jpg (GRAPHIC) — 32KB
• 0000720005-25-000095.txt ( ) — 239KB
• rjf-20251203.xsd (EX-101.SCH) — 3KB
• rjf-20251203_def.xml (EX-101.DEF) — 15KB
• rjf-20251203_lab.xml (EX-101.LAB) — 27KB
• rjf-20251203_pre.xml (EX-101.PRE) — 16KB
• rjf-20251203_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On December 3, 2025, the Company issued a press release (the "Press Release") announcing that the Board had declared on December 3, 2025 a quarterly dividend of $0.54 per share for each outstanding share of common stock of the Company. The dividend is payable on January 16, 2026 to shareholders of record on January 2, 2026. The Press Release also announced that the Board declared a quarterly cash dividend of $0.3984375 per depositary share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (NYSE: RJF PrB), payable January 1, 2026 to shareholders of record on December 15, 2025. A copy of the Press Release is attached to this Current Report as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1 hereto, is being "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company with the Securities and Exchange Commission, whether made before or after the date hereof, regardless of any general incorporation language in such filings (unless the Company specifically states that the information or exhibit in this particular report is incorporated by reference).

01 Other Events

Item 8.01 Other Events The Press Release also announced that the Board had authorized repurchase of the Company's shares of common stock ("Common Stock") in an aggregate amount of up to $2 billion. The $2 billion authorization replaces the previous repurchase authorization of $1.5 billion announced on December 3, 2024, under which approximately $105 million was remaining as of December 2, 2025. The repurchases may be made from time to time at prices that the company deems appropriate and subject to market conditions, applicable law, regulatory constraints in connection with previously announced acquisitions and other factors. Such repurchases may be made in the open market, in privately negotiated transactions, or otherwise. The Board's authorization does not have a fixed expiration date. The repurchase authorization does not obligate the company to repurchase any dollar amount or number of securities and may be suspended or discontinued at any time. Information regarding repurchases of Common Stock will be available in the Company's periodic reports on Form 10-Q and 10-K filed with the Securities and Exchange Commission as required by the applicable rules of the Exchange Act.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. The following are filed as exhibits to this report: Exhibit No. Description 99.1 Press release, dated December 3 , 2025, issued by Raymond James Financial, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAYMOND JAMES FINANCIAL, INC. Date: December 4, 2025 By: /s/ Jonathan W. Oorlog, Jr. Jonathan W. Oorlog, Jr. Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR